Skip to main content

Johnson & Johnson

JNJHealthcare
CIK 0008855001SIC 3571Pharmaceuticals
Market Cap

$4.8B

+2.4% today
Sector & Industry

Healthcare

Pharmaceuticals

SEC Filings

140

Total filings on record

Last Filing

Feb 1, 2026

8-K — Board of Directors Update

Showing 15 filings
Form TypeFiled DateAcceptedDescriptionAccessionActions
10-KFeb 1, 2026Feb 1, 2026Annual Report for fiscal year ended March 20250008855001-26-724622
10-KJan 2, 2026Jan 2, 2026Annual Report for fiscal year ended January 20250008855001-26-621274
10-QNov 26, 2025Nov 26, 2025Quarterly Report for period ended September 20250008855001-26-318796
8-KNov 5, 2025Nov 5, 2025Current Report - Material Event Disclosure0008855001-26-526524
8-KOct 11, 2025Oct 11, 2025Current Report - Material Event Disclosure0008855001-26-519943
Form 4Sep 9, 2025Sep 9, 2025Statement of Changes - James Johnson0008855001-26-464611
13FAug 11, 2025Aug 11, 2025Institutional Investment Manager Holdings Report0008855001-26-222394
10-QJul 11, 2025Jul 11, 2025Quarterly Report for period ended September 20250008855001-26-811849
8-KJun 21, 2025Jun 21, 2025Current Report - Material Event Disclosure0008855001-26-636744
10-KMay 25, 2025May 25, 2025Annual Report for fiscal year ended March 20250008855001-26-204483
10-QApr 17, 2025Apr 17, 2025Quarterly Report for period ended March 20250008855001-25-536467
8-KMar 24, 2025Mar 24, 2025Current Report - Material Event Disclosure0008855001-25-537641
DEF 14AFeb 25, 2025Feb 25, 2025Definitive Proxy Statement for Annual Meeting0008855001-25-986795
10-KJan 25, 2025Jan 25, 2025Annual Report for fiscal year ended December 20250008855001-25-217233
10-KJan 5, 2025Jan 5, 2025Annual Report for fiscal year ended December 20250008855001-25-767796